Analysis of Fisher Wallace Laboratories Release: The Fisher Wallace Stimulator Approved By New York City Health And Hospitals Corporation - aVenture Research
BioSpace
Fisher Wallace Laboratories Release: The Fisher Wallace Stimulator Approved By New York City Health And Hospitals Corporation
NEW YORK, March 26, 2015 /PRNewswire/ -- Fisher Wallace Laboratories today announced that its popular neurostimulation device, called the Fisher Wallace Stimulator®, has been approved by New York City Health and Hospitals Corporation (NYC HHC). New York City Health and Hospitals Corporation is comprised of eleven of New York City's largest hospitals, including Bellevue Hospital, Woodhull Hospital and Metropolitan Hospital. Woodhull Hospital is already using the device with patients.
An analysis reads this article and its sources, then explains what happened, who is involved, and what it means, quoting a source for each claim. Once written, every reader sees it here.
Analysis requires a paid plan or prepaid credits and uses your company research allowance.